Eli Lilly & Co. to buy U.S. gut-drug maker Morphic Holding Inc. for $3.2 billion
Eli Lilly & Co., a global leader in pharmaceuticals, has announced the acquisition of Morphic Holding ...
Read more
Eli Lilly & Co., a global leader in pharmaceuticals, has announced the acquisition of Morphic Holding ...
Read more